Căutare | ValuTok

Rahul Rangwa a adăugat un sunet Alte
2026-03-11 06:52:28

mTOR Inhibitor Oncology Drug Market Grows with Breakthroughs in Targeted Cancer Therapy
"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Forecast CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Competitive analysis performed in this mTOR Inhibitor Oncology Drug Market...

0 Commentarii 0 Distribuiri 495 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Naznin Shaikh a adăugat un sunet Dance
2026-03-06 08:53:30

Antibody Drug Conjugates Market Expansion with New Cancer Therapies
North America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...

0 Commentarii 0 Distribuiri 1K Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
KUMUD SINGH a adăugat un sunet Health
2026-03-27 12:54:41

Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%
According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...

0 Commentarii 0 Distribuiri 140 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Naznin Shaikh a adăugat un sunet Health
2026-03-06 09:22:22

Investment Trends in the Anti-cancer Drugs Market
The increasing focus on biologics and biosimilars is transforming the anti-cancer drugs industry. These advanced therapies offer new treatment options for patients with complex cancers. Their rising adoption is expected to drive long-term market expansion. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and increasing...

0 Commentarii 0 Distribuiri 1K Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Komal Galande a adăugat un sunet Crafts
2026-03-12 08:01:20

Is the Global Colorectal Cancer Treatment Market Advancing with Breakthrough Oncology Therapies?
Executive Summary Colorectal Cancer Treatment Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Market drivers and market restraints...

0 Commentarii 0 Distribuiri 868 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Mikel Watson a adăugat un sunet Alte
2026-03-25 15:37:38

Oncology Small Molecule Drugs Market Growth Factors, Opportunities, Drivers, Strategies, Trends, and Forecast to 2031
The Oncology Small Molecule Drugs Market is experiencing accelerated interest and investment as global healthcare systems intensify efforts to improve cancer care outcomes. According to the Oncology Small Molecule Drugs Market report by The Insight Partners, this market is anticipated to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2031, underscoring sustained momentum in...

0 Commentarii 0 Distribuiri 188 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Komal Galande a adăugat un sunet Crafts
2026-03-16 06:07:42

Will Endocrine Resistance-Targeting Drugs Transform the Future of Cancer Therapy?
Market Trends Shaping Executive Summary Endocrine Resistance–Targeting Drug Market Market Size and Share CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...

0 Commentarii 0 Distribuiri 667 Views 0 previzualizare

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!